Edition:
United States

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

4.14USD
3:59pm EST
Change (% chg)

$-0.13 (-3.04%)
Prev Close
$4.27
Open
$4.20
Day's High
$4.26
Day's Low
$4.07
Volume
5,355
Avg. Vol
18,956
52-wk High
$12.09
52-wk Low
$3.10

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 20 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-18 2 148.51 148.90 148.12 204.40
Earnings (per share)
Year Ending Dec-18 2 -3.61 -1.14 -6.08 -1.20

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 35.95 28.67 7.28 20.25
Quarter Ending Jun-17 36.86 40.88 4.02 10.91
Quarter Ending Mar-17 35.55 29.98 5.57 15.66
Quarter Ending Dec-16 40.10 13.57 26.53 66.15
Quarter Ending Sep-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-18 148.51 148.51 155.00 155.00 204.40

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-18 0 0 0 1
Earnings